Abstract The aim of the study was to describe the presentation management and short term results of therapy (< 1 month) in patients admitted with HIV vasculopathy.
The largest burden of human immunodeficiency virus acquired immunodeficiency syndrome (HIV/AIDS) is found in sub-Saharan Africa, which accounts for approximately 60% of people living with HIV worldwide. 1 The HIV virus is a lentovirus, which invades lymphoid tissue and can also be found in all bodily fluids. Particularly clinically relevant are the genital secretions, breast milk and blood. The HIV-1 viruses are found universally and there are 11 subtypes. HIV-2 was found in West Africa and has four subtypes. This is the Simian immunodeficiency virus and the infection runs a much milder clinical course.
The natural history of the disease comprises an initial acute illness, which lasts for a week or two followed by a long quiescent phase, which may last for years during which the immune system is progressively destroyed. The terminal events are characterised by opportunistic infections and other acquired immunodeficiency syndrome (AIDS)-defining conditions.
Monitoring during the quiescent phase entails measuring the serum CD4 count and viral load. Antiretroviral therapy is effective during this phase of the disease and inhibits viral replication. Vasculopathies occur during the later stages of the disease process and are a marker for advanced disease.
HIV-related aneurysms were first reported in Zimbabwe. 2, 3 Nair et al. 4 first described the pathology in detail, which was regarded as unique to HIV/AIDS vasculopathy. They noted that the inflammation was centred on the vasa vasora in the adventitia and was characterised by a vasculitis in which the vessels were surrounded by a cuff of neutrophils, monocytes and plasma cells, which ultimately lead to occlusion of the vasa vasora with resultant transmural fibrosis or necrosis and the formation of true or false aneurysms. The exact pathogenesis is uncertain and there is debate as to whether this is due to direct action of the virus or an immune-complex mechanism. HIV protein is noted in the lymphocytes of the vasa vasora but this can be found in lymphocytes throughout the body. The obvious question is whether opportunistic bacterial infection is responsible. Studies on 92 aneurysms, which included cultures and polymerase chain reaction (PCR) investigation, revealed positive cultures in only three, which comprised mixed organisms grown from an aneurysm clot. 5 Occlusive disease is less well studied. HIV-related thrombosis, which is segmental, shows a histological picture identical to that seen in aneurysms, with inflammatory changes confined to the vasa vasora with bland organising luminal thrombosis. This strongly suggests that aneurysm and thrombosis are different expressions of the same pathological process. There is also evidence to suggest that HIV infection promotes the development of accelerated atherosclerosis due to endothelial damage. This article presents a review of a 4-year experience with HIV-related vasculopathies treated at the vascular service at the Inkosi Albert Luthuli Central Hospital in Durban, South Africa. ).
Patients and Methods
Aneurysms Table 1 shows the anatomical distribution of aneurysms and it will be seen that they tend to be multiple. There were a total of 202 aneurysms in 111 patients. The most common site is the superficial femoral artery (40%) followed by the carotid artery (25%). In Table 2 , the clinical presentation of aneurysms is summarised. Almost half (45%) were asymptomatic, presenting with a pulsatile mass or were incidentally discovered on ultrasound or plain radiography, while 55% presented with rupture or compressive symptoms. A total of 36% had manifestations of advanced HIV disease with weight loss, adenopathy or opportunistic infections such as candidiasis or pneumonia. Radiographs showing typical aneurysms are displayed in Fig. 1 .
Treatment of the aneurysm is shown in Table 3 in which 119 aneurysms were treated in 111 patients. A total of 29 patients (24%) were assessed to be too ill for treatment due to advanced disease or they refused treatment.
Operative repair was offered to 82 patients (69%); 32 aortic replacements, 28 carotid repairs and 20 lower limb repairs were performed. These used standard replacement techniques using prosthetic grafts in 57 (70%) or vein grafts in 25 (30%).
More recently, stent grafts have been used in eight patients; subclavian in four, carotids in three and aorta in one.
The results of aneurysm treatment within 1 month of the procedures can be seen in Table 4 . Following 32 aortic replacements, three patients died (9%) e all of multipleorgan failure while three of 28 patients with carotid replacement died (11%). One of 22 patients with lower limb reconstructions died (4%) and one of the eight stented patients died following a subclavian procedure in which the stent became infected resulting in exsanguinating haemorrhage 2 weeks later.
The overall mortality in the total of 80 patients submitted to surgery was 9%, with 5% developing graft sepsis and 11% significant pulmonary infection.
All postoperative results are reported at 1 month after operation. The hospital is a tertiary referral centre and patients are then referred back to base hospitals for further long-term therapy. At this stage, reliable longer term results are not available. Table 5 summarises the clinical presentation of the 115 patients with occlusive disease.
Occlusive Disease
There were two distinct groupseone in which there was no antecedent claudication and who presented with acute thrombosis. Angiographically, proximal vessels appeared normal but there was segmental occlusion with poor distal runoff. A typical angiogram is shown in Fig. 2 . It is of interest to note that duplex Doppler showed what appeared to be a pathognomonic beading in the vessel wall (Fig. 3) .
A total of 51 patients presented with acute thrombosis (44%). The coagulation profile, which included international normalised ratio (INR) platelet count, protein C and S levels, antilupus antibody, serum fibrinogen and antiphospholipid antibody revealed no abnormalities. This comprehensive investigation was carried out in only 15 patients, as economic factors precluded this as a routine. The second group with occlusive disease appeared to have premature atherosclerotic disease and it comprised 64 patients (56%). The majority presented with critical ischaemia with rest pain or gangrene.
Management of the acute thrombosis group is shown in Table 6 . Fifteen (29%) patients had primary amputation as the limbs were deemed unsalvageable. In 33 of 36 (71%) patients, salvage was attempted comprising thrombectomy with or without thrombolysis; bypass was attempted in the remaining three patients. Of the 64 patients, who had chronic occlusive disease, primary amputation was necessary in 30 (47%) while no treatment was offered to nine (14%) who were deemed to be preterminal. Twenty-one patients were offered bypass surgery, and four an endovascular procedure (Table 7) .
Results within 1 month of attempted limb salvage in 36 patients with acute thrombosis are shown in Table 8 . Limb salvage was achieved in 13 (36%), while 23 (64%) resulted in an amputation. Four patients in this group died (11%).
Of 25 patients in the chronic occlusive group, salvage was achieved in 17 (68%) while eight (32%) resulted in amputation. Three patients (12%) died.
Of the entire group of 115 patients presenting with occlusive disease, the limb salvage rate was 26% and the mortality rate 6% (Table 9 ).
In the entire group including aneurysms as well as occlusive disease, an attempt was made to correlate the incidence of postoperative complications with the level of serum albumin and the CD4 count in 110 patients in whom the information was complete. Serum albumin of 
Discussion
There is an increasing incidence of HIV-related vasculopathy in our practice.
While females are most commonly affected by HIV infection in our environment, there is a distinct male predominance in HIV vasculopathy. This corroborates other reports, but the reason for this is obscure. 5, 6, 12, 13 The HIV vasculopathies are a manifestation of advanced disease as evidenced by the low average CD4 count of only 255 cells mm À3 in this series, which is a finding similar to those published by other authors. 5, 6, 12, 13 A total of 26% of patients with aneurysms and 9% of our occlusive disease patients were not offered treatment due to the severity of the systemic illness.
The multiplicity and sites of the aneurysms is also difficult to explain. As a general principle, if an aneurysm is found, then other sites should be screened for multiple lesions.
Standard treatment has been offered for aneurysms, including prosthetic grafts, and relatively recently, endovascular therapy has been performed. Due to the fact that the hospital is a tertiary level centre and patients are discharged to peripheral hospitals for further long-term therapy, the only reliable follow-up that we have to report is for 1 month after the surgery. There is a smaller cohort that has been followed up for 1 year and longer but the information is not suitable for analysis and publication at this stage. In the short term, perioperative mortality is surprisingly low for all procedures. The most common postoperative complication is pneumonia which, in those that died in the perioperative period, progressively deteriorated and resulted in multiple-organ dysfunction. The death that occurred following endovascular therapy followed a stent that was inserted into a subclavian aneurysm, which became grossly septic within the next 2e3 weeks with resultant massive secondary haemorrhage.
In the short term, sepsis of both graft and wound is relatively low. We have, however, seen some patients returning within 6 months with a graft infection.
In relation to the occlusive disease, there appear to be two distinct patterns. One is that of acute thrombosis originally described by Mulaudzi et al. 8 in which patients have had minimal symptoms before presenting with acute ischaemia and rest pain. The other group presents with chronic ischaemia due to atherosclerosis.
In the acute thrombosis group, the angiographic picture is one in which the proximal vessels are normal, accompanied by aggressive peripheral thrombotic occlusion and very poor distal runoff. Duplex Doppler shows a characteristic picture of a 'string of beads' in the wall of the vessel; the exact reason for this is uncertain, but it appears to be pathognomonic. This has been described from our centre in an earlier publication. Of interest is that the coagulation profile, which was unfortunately done only in 15 patients due to economic constraints, showed no significant abnormalities. This corroborates an earlier report. 8 Hence, we believe that the major problem with the acute thrombotic occlusion is that of the arteritic process resulting in thrombosis.
Venous thrombosis has been noted as a complication of advanced disease and the impression is that there is a prothrombotic process under these circumstances. Deep-vein thrombosis was noted in only 5% of this particular group of patients.
In studies on HIV-related venous thrombosis, several authors have demonstrated protein S deficiency and this is the only convincing evidence of an element of a prothrombotic state.
15e17 Others have noted anticardiolipin antibodies, 18 and protein C deficiency 19 but there is no clear evidence for any particular thrombophilia, and this is probably a multifactorial phenomenon.
In the acute arterial thrombosis group in the present series, 30% were beyond salvage and had a primary amputation. Thrombectomy and thrombolysis resulted in a 36% salvage rate, with an 11% mortality related mainly to pulmonary complications.
In the group with chronic occlusive disease, 90% of the patients presented with critical ischaemia with focal gangrene and rest pain. This was thought to be due to atherosclerotic lesions occurring in a much younger group of patients. It seems that peripheral arterial disease is more prevalent with HIV infection and a six-fold increase has been shown at an earlier stage compared with HIV-negative patients.
9e11 Due to the advanced disease, in almost half of the patients, there was no possibility of reconstruction due to poor runoff or the limb was beyond salvage. Standard bypass procedures were performed in most patients and only recently have endovascular procedures been attempted in our practice. In this group, the results are marginally better than in the patients with acute thrombosis in that there was a 68% salvage rate at 1 month with 12% mortality. In the series of van Marle et al., 6 the results were very similar at 1 month, and on follow-up of a limited number of patients in the longer term, it was found that the amputation rate rose to approximately 29%.
In terms of prognostication as to which patients will survive operation, some authors have noted that the CD4 count is important whilst others feel that the albumin, as a reflection of nutrition, is important; but this is not borne out in our own experience. 20e24 In general, the incidence of sepsis is surprisingly low in the short term, but it would appear that this increases in the longer term, particularly in relation to graft infections.
A major issue is what the impact of antiretroviral therapy might be on therapy for vasculopathies. Vasculopathy is a late manifestation of disease and could possibly be construed as AIDS defining. It would appear that antiretroviral therapy may influence the postoperative results and there is a desperate need for more accurate follow-up and documentation in the longer term.
In conclusion, surgical therapy for aneurysms is worthwhile, in the short term.
Among the occlusive disease patients, there is an overall approximate salvage rate of 25% and how this would be carried into the longer term remains to be seen. It may be argued that primary amputation for all patients may be a better option. The influence of antiretroviral therapy requires definition.
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